Search

everythinglearnresearchcommunity

for

Search:↓

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Alopecia Areata might be linked to Crohn's disease.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Apremilast did not work for treating severe alopecia areata.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Sorafenib may cause hair loss in a way similar to alopecia areata.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Activating TLR3 improves the healing and immune properties of periodontal ligament stem cells.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.